Natural Product Sciences

The Korean Society of Pharmacognosy (한국생약학회)
권호 표지
DOI QR코드

DOI QR Code

The Suppression Effect of Garcinia Mangostana L. Pericarp Extract on Cerebral Neovascularization in Type 2 Diabetic Mellitus Rats

  • Muhammad Mufaiduddin (Department of Medicine, Faculty of Medicine, Universitas Diponegoro) ;
  • Vega Karlowee (Department of Anatomical Pathology, Faculty of Medicine, Universitas Diponegoro) ;
  • Yora Nindita (Department of Pharmacology and Therapy, Faculty of Medicine, Universitas Diponegoro) ;
  • Muflihatul Muniroh (Department of Physiology, Faculty of Medicine, Universitas Diponegoro)
  • Received : 2022.05.19
  • Accepted : 2023.04.26
  • Published : 2023.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

Mangosteen peel extract is a xanthone group, that plays an important role in anti-angiogenesis. This study investigated mangosteen peel extract on cerebral neovascularization in type 2 diabetes mellitus (DM) rats. This study used 36 rats, randomized into six groups: C1 (negative control); C2 (high fat diet (HFD) and mangosteen peel extract at 200 mg/kg BW); C3 (HFD and diabetic); E1, E2, and E3 (HFD, diabetic, and extract at 100, 200, and 400 mg/kg BW respectively). All groups were measured body mass index (BMI), homeostasis model assessment-insulin resistance (HOMA-IR) and β cell function (HOMA-B), and histopathological feature of cerebral vascular (CV). There were significant differences in BMI, HOMA-IR, HOMA-B, and the mean number of CV (all p < 0.05) among treatment groups. E1-3 groups had a significantly lower level of blood glucose and HOMA-IR, and a higher level of HOMA-B and BMI (all p < 0.05) which tends to reduce cerebral neovascularization. HOMA-IR independently had a positive effect to induce neovascularization of CV (p < 0.05, R2 = 26.8%). These findings suggested that mangosteen peel extract increased β-cell function sensitivity, and effectively suppressed insulin resistance, BMI, and cerebral neovascularization process in type 2 DM rats.

Keywords

Acknowledgement

The authors are grateful to Grant Consortium No. 201-04/UN7.6.1/PP/2020 for financial support in this study.

References

  1. Jaipersad, A. S.; Lip, G. Y.; Silverman, S.; Shantsila, E. J. Am. Coll. Cardiol. 2014, 63, 1-11. https://doi.org/10.1016/j.jacc.2013.09.019
  2. Persson, A. B.; Buschmann, I. R. Front. Mol. Neurosci. 2011, 4, 14.
  3. Li, W.; Prakash, R.; Kelly-Cobbs, A. I.; Ogbi, S.; Kozak, A.; El-Remessy, A. B.; Schreihofer, D. A.; Fagan, S. C.; Ergul, A. Diabetes 2010, 59, 228-235. https://doi.org/10.2337/db09-0902
  4. Taher, M.; Tg Zakaria, T. M.; Susanti, D.; Zakaria, Z. A. BMC Complement. Altern. Med. 2016, 16, 135.
  5. Mohan, S.; Syam, S.; Abdelwahab, S. I.; Thangavel, N. Food Funct. 2018, 9, 3860-3871. https://doi.org/10.1039/C8FO00439K
  6. Abate, M.; Pagano, C.; Masullo, M.; Citro, M.; Pisanti, S.; Piacente, S.; Bifulco, M. Pharmaceuticals (Basel) 2022, 15, 84. https://doi.org/10.3390/ph15010084
  7. da Silva Gomes, E. C.; Jimenez, G. C.; da Silva, L. C.; de Sa, F. B.; de Souza, K. P.; Paiva, G. S.; de Souza, I. A. J. Cancer 2014, 5, 143-150. https://doi.org/10.7150/jca.7439
  8. Shukla, K.; Sonowal, H.; Saxena, A.; Ramana, K. V. Vascul. Pharmacol. 2019, 115, 18-25.
  9. Muniroh, M.; Nindita, Y.; Karlowee, V.; Purwoko, Y.; Rahmah, N. D.; Widyowati, R.; Suryono, S. Biomed. Rep. 2021, 15, 63.
  10. Suryono, S.; Hadiyanto, H.; Yasin, M.; Widyowati, R.; Muniroh, M.; Amalia, A. E3S Web Conf. 2019, 125, 25006.
  11. Peniati, E.; Setiadi, E.; Susanti, R.; Iswari, R. S. J. Phys. Conf. Ser. 2018, 983, 1-6. https://doi.org/10.1088/1742-6596/983/1/012185
  12. Alizadeh-Fanalou, S.; Babaei, M.; Hosseini, A.; Azadi, N.; Nazarizadeh, A.; Shojaii, A.; Borji, M.; Malekinejad, H.; Bahreini, E. J. Ethnopharmacol. 2020, 248, 112331.
  13. Song, Y.; Manson, J. E.; Tinker, L.; Howard, B. V.; Kuller, L. H.; Nathan, L.; Rifai, N.; Liu, S. Diabetes Care 2007, 30, 1747-1752. https://doi.org/10.2337/dc07-0358
  14. Husen, S. A.; Kalqutny, S. H.; Ansori, A. N. M.; Susilo, R. J. K.; Alymahdy, A. D.; Winarni, D. Biosci. Res. 2017, 14, 1238-1245.
  15. Chan, C. P.; Koong, L. J.; Stern, J. S. Am. J. Physiol. 1982, 242, E19-E24.
  16. Antunes, L. C.; Elkfury, J. L.; Jornada, M. N.; Foletto, K. C.; Bertoluci, M. C. Arch. Endocrinol. Metab. 2016, 60, 138-142. https://doi.org/10.1590/2359-3997000000169
  17. Watanabe, M.; Gangitano, E.; Francomano, D.; Addessi, E.; Toscano, R.; Costantini, D.; Tuccinardi, D.; Mariani, S.; Basciani, S.; Spera, G.; Gnessi, L.; Lubrano, C. Nutrients 2018, 10, 586. https://doi.org/10.3390/nu10050586
  18. Kim, K.; Park, S. M. Sci. Rep. 2018, 8, 2703.
  19. Ahmad, F. K.; He, Z.; King, G. L. Curr. Drug Targets 2005, 6, 487-494. https://doi.org/10.2174/1389450054021990
  20. Kota, S. K.; Meher, L. K.; Jammula, S.; Kota, S. K.; Krishna, S. V.; Modi, K. D. Indian J. Endocrinol. Metab. 2012, 16, 918-930. https://doi.org/10.4103/2230-8210.102992
  21. Yoshinaga, N.; Arimura, N.; Otsuka, H.; Kawahara, K.; Hashiguchi, T.; Maruyama, I.; Sakamoto, T. Lab. Invest. 2011, 91, 1277-1290. https://doi.org/10.1038/labinvest.2011.101
  22. Wihastuti, T. A.; Sargowo, D.; Tjokroprawiro, A.; Permatasari, N.; Widodo, M. A.; Soeharto, S. Vasc. Health Risk Manag. 2014, 10, 523-531. https://doi.org/10.2147/VHRM.S61736
  23. Widowati, W.; Ginting, C. N.; Lister, I. N. E.; Girsang, E.; Amalia, A.; Wibowo, S. H. B.; Kusuma, H. S. W.; Rizal. Trop. Life Sci. Res. 2020, 31, 127-144.
  24. Anwar, A. I.; Djawad, K.; Fitri, E. W. Pak. J. Nutr. 2016, 15, 745-751. https://doi.org/10.3923/pjn.2016.745.751
  25. Coucha, M.; Abdelsaid, M.; Ward, R.; Abdul, Y.; Ergul, A. Compr. Physiol. 2018, 8, 773-799.  https://doi.org/10.1002/cphy.c170019